Retina Subspecialty Day

Sunday, 6 June 2010, 08:30 - 10:00 hrs

Retinal Detachment and PVR

 

Chairs:
Alain Gaudric (Paris, France)
George William Aylward (London, United Kingdom)

08:30

Surgical instrumentation for RD and PVR repair (20, 23, 25 g etc.)
Constantin J. Pournaras (Geneva, Switzerland)

08:40

Which new drugs can treat PVR?
Louisa Wickham (London, United Kingdom)

08:50 

Is there still place for scleral buckling in primary surgery for RD?
Heinrich Heimann (Liverpool, United Kingdom)

09:00 

Management after failure of primary RD-repair
Periklis Brazitikos (Athens, Greece)

09:10 

Prevention of RD: are there cases in which it is worthwhile
Fred Hendrikse (Maastricht, The Netherlands)

09:20 

Management of second eye in vitreoretinal dystrophies
Anthonio Capone Jr. (Oakland, United States)

09:30

Trauma and vitreoretinal surgery - timing and management
Masahito Ohji (Otsu, Japan)

09:40

Intraocular tamponade - what’s new
David Wong (Pok Fu Lam, China)

09:50

“Hot topic”
How Tamponades Work in Retinal Detachment – is post-operative positioning really necessary?
George William Aylward (London, United Kingdom)

 

Sunday, 6 June 2010, 10:30 - 12:00 hrs

Vitreoretinal Interface – Epiretinal Macular Surgery

 

Chairs:
Alain Gaudric (Paris, France)
Michael T. Trese (Royal Oak, United States)

10:30 

Pathology of the vitreoretinal interface: Implications for surgery
Arnd Gandorfer (München, Germany)

10:40 

Microplasmin to treat vitreomacular traction: results of a phase III clinical trial (MIVI-006)
Matthew Benz (Houston, USA)

10:50

Progress in epiretinal surgery: vital stains
Christos Haritoglou (München, Germany)

11:00 

Macular hole surgery: is face-down positioning still necessary?
Louisa Wickham (London, United Kingdom)

11:10 

Macular hole surgery: is ILM peeling always useful?
Ramin Tadayoni (Paris, France)

11:20 

ERM and VMTS surgery: cases which fail
Thomas J. Wolfensberger (Lausanne, Switzerland)

11:30 

Vitreoretinal interface in AMD
Susanne Binder (Wien, Austria)

11:40 

Vitreoretinal Interface in children – therapeutic implications
Michael T. Trese (Royal Oak, United States)

11:50

“Hot topic”
Round Table discussion: How to treat macular holes
Alain Gaudric (Moderator), Michael T. Trese, Anselm Kampik, George William Aylward

 

Sunday, 6 June 2010, 14:00 - 15:30 hrs

Retinal Vascular Diseases: Diabetic Retinopathy / Vein Occlusions

 

Chairs:
Michael T. Trese (Royal Oak, United States)
Anselm Kampik (München, Germany)

14:00

Pathogenesis leading to pharmacologic treatment in retinal vascular diseases
Einar Stefánsson (Reykjavik, Iceland)

14:10

Steroids vs laser in DME
Pascale Massin (Paris, France)

14:20

Anti VEGFs vs Steroids in DME
Julia A. Haller (Philadelphia, United States)

14:30

Slow release steroids in DME
Frank G. Holz (Bonn, Germany)

14:40

Combination of pharmacology and VR surgery in DR
J. Fernando Arevalo (Caracas, Venezuela)

14:50

Does early intravitreal drug therapy change the course of BRVO and CVRO
Francesco Bandello (Milano, Italy)

15:00

Is surgery useful in BRVO and CRVO
José García Arumí (Barcelona, Spain)

15:10

“Hot topic”
Frank G. Holz will include the results of the FAME study in his talk

15:20 

“Hot topic”
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
Lloyd Aiello (Boston, United States)

 

Sunday, 6 June 2010, 16:00 - 17:30 hrs

AMD

 

Chairs:
Anselm Kampik (München, Germany)
George William Aylward (London, United Kingdom)

16:00

When to stop anti VEGF therapy?
Adnan Tufail (London, United Kingdom)

16:10

Update on Clinical Trials of Intravitreal Drugs for Neovascular AMD
Alexander J. Brucker (Philadelphia, USA)

16:20

Geographic atrophy: Imaging Metrics and Progression Determinants
Frank G. Holz (Bonn, Germany)

16:30

Future drugs for treatment of dry AMD
Salvatore Grisanti (Lübeck, Germany)

16:40

Genetics and prevention of AMD
Hendrik P. N. Scholl (Bonn, Germany)

16:50

Is there a place for surgery in AMD?
Jan van Meurs (Rotterdam, The Netherlands)

17:00

Cell therapy for AMD
Victor Chong (London, United Kingdom)

17:10

How to prevent endophthalmitis in intravitreal therapy?
Thierry C. Verstraeten (Pittsburgh, USA)

17:20 

“Hot topic”
Avastin (Bevacizumab) for Choroidal Neovascularisation (ABC Trial)
Adnan Tufail (London, United Kingdom)